Tempus AI Completes Acquisition of Ambry Genetics

Share via:


Tempus AI Completes Acquisition of Ambry Genetics
Tempus AI, an artificial intelligence-driven precision medicine company, has completed its acquisition of Ambry Genetics, a genetic testing company focused on improving health by understanding the relationship between genetics and disease. The deal, valued at USD 600 million, includes USD 375 million in cash and USD 225 million in shares, with USD 100 million subject to a one-year lock-up. Financing was provided by Ares Management Credit Funds.

Also Read: Corti Launches Specialised AI Models for Healthcare

Tempus AI Acquires Ambry Genetics

The…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

admin
admin
Hi! This is Admin.

Popular

More Like this

Tempus AI Completes Acquisition of Ambry Genetics


Tempus AI Completes Acquisition of Ambry Genetics
Tempus AI, an artificial intelligence-driven precision medicine company, has completed its acquisition of Ambry Genetics, a genetic testing company focused on improving health by understanding the relationship between genetics and disease. The deal, valued at USD 600 million, includes USD 375 million in cash and USD 225 million in shares, with USD 100 million subject to a one-year lock-up. Financing was provided by Ares Management Credit Funds.

Also Read: Corti Launches Specialised AI Models for Healthcare

Tempus AI Acquires Ambry Genetics

The…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

admin
admin
Hi! This is Admin.

More like this

Revisiting Windows 1.0: how Microsoft’s first desktop gracefully failed

Editor’s note: Ahead of Microsoft’s 50th’s anniversary, we’ve...

RateGain Continues Downward Slide, Hits Fresh 52-Week Low

SUMMARY It has declined over 10.59% in the last...

Banks acting as validators risks centralization — Everstake exec

New US regulatory guidance allowing banks to become...

Popular

Upcoming Events

Purple Style Labs Bags $40 Mn To Strengthen Its...

SUMMARY The investment was led by SageOne Flagship Growth...

How ADA Coin is Powering Innovation in the Startup...

With the rapid advancement of technology, the startup sphere...

Anthropic CEO says spies are after $100M AI secrets...

Anthropic’s CEO Dario Amodei is worried that spies,...
d.fesdfrwa.dfa d.fesdfrwa.dfa d.fesdfrwa.dfa d.fesdfrwa.dfa d.fesdfrwa.dfa d.fesdfrwa.dfa d.fesdfrwa.dfa d.fesdfrwa.dfa d.fesdfrwa.dfa d.fesdfrwa.dfa